![]() | This article may contain an excessive amount of intricate detail that may interest only a particular audience. (March 2017) |
Jacques Leibowitch | |
---|---|
![]() | |
Born | Clermont-Ferrand, France | 1 August 1942
Died | 4 March 2020 Massy, France | (aged 77)
Known for | Identification of HIV as retro-virus, world pioneer use of tri-therapy treatment |
Spouse | |
Awards | Chevaliers of the Légion d'honneur |
Scientific career | |
Fields | HIV research |
Institutions | Raymond Poincaré University Hospital |
Jacques Leibowitch (1 August 1942 – 4 March 2020[1]) was a French medical doctor and clinical researcher known for his contributions to the knowledge and treatment of HIV and AIDS, starting with his initial designation of a human retrovirus as the cause of AIDS, and his ground-breaking use of triple combination therapy for the effective control of HIV in the patient. A practicing physician in the infectiology department of the Raymond Poincaré University Hospital of Garches (directed by Prof. Christian Perronne, AP-HP), University lecturer Emeritus, he led the treatment program ICCARRE that proposes a dramatic reduction of weekly anti-HIV drug intake, down to 2-3 anti-viral pills a day taken 2 to 3 or 4 days a week, as opposed to the presently recommended seven days a week, as still universally prescribed. These reduced medical dosages are adequate, necessary and sufficient according to the results of his exploratory clinical research carried out since 2003. He is the author of the books "Un virus étrange venu d'ailleurs" (A strange virus of unknown origin),[2] and "Pour en finir avec le sida" (Putting an end to AIDS).[3]